Core Viewpoint - Xinhua Medical has a high employee count compared to other medical device companies due to its comprehensive business layout and complete industry chain, operating across four major sectors: medical devices, pharmaceutical equipment, medical trade, and medical services [2] Company Summary - Xinhua Medical is not just a manufacturer of medical devices but has developed a diversified industrial structure that supports collaborative development across multiple sectors [2] - The company's business layout requires personnel support across various functions including production, research and development, sales, and services, leading to a higher total employee count compared to companies focused on a single niche [2]

（文章来源：证券日报） 证券日报网讯 12月4日，新华医疗在互动平台回答投资者提问时表示，关于收购中帜生物项目的进展， 敬请关注公司后续公告。 ...

Core Viewpoint - The company emphasizes its commitment to addressing stock price volatility and enhancing its core competitiveness and intrinsic value through various strategic initiatives [1] Group 1: Company Strategy - The company is focused on optimizing its business layout to ensure sustainable development [1] - The company aims to strengthen technological innovation as a key driver for growth [1] - The company is working to improve operational efficiency to create greater value for shareholders [1]

证券日报网讯 12月4日，新华医疗在互动平台回答投资者提问时表示，股价波动受宏观经济、行业周 期、市场情绪等多重因素综合影响，短期走势未能完全反映公司内在价值。当前行业环境虽存挑战，但 公司始终聚焦主业、稳健经营，持续推进核心业务升级与产品布局。后续公司将严格依规做好信息披 露，加强与投资者沟通，积极做好市值管理。 （编辑 丛可心 袁冠琳） ...

（编辑 姚尧） 证券日报网讯 12月4日，新华医疗在互动平台回答投资者提问时表示，新华医疗在信息披露过程中，严 格区分控股股东的法定权利与违规获取信息的边界。公司不存在违反《上市公司信息披露管理办法》的 情形。 ...

证券日报网讯 12月4日，新华医疗在互动平台回答投资者提问时表示，市值差异本质是市场对传统制造 业与创新科技企业的估值逻辑分化。公司重视市值管理，正积极通过控股股东增持、优化分红、完善治 理结构、实施股权激励等方式方法进行市值管理。 （编辑 姚尧） ...

证券日报网讯 12月4日，新华医疗在互动平台回答投资者提问时表示，四季度中标节奏与一季度、二季 度保持平稳态势，公司将持续推进订单的落地与执行。股价走势同时受宏观经济、行业周期、市场情绪 等多种外部因素作用。公司将持续聚焦主业发展，不断丰富产品体系、优化经营策略，努力以稳健的经 营业绩回馈投资者。 （编辑 丛可心 袁冠琳） ...

Core Viewpoint - Xinhua Medical has received medical device registration certificates for its surgical shadowless lamp and thoracoabdominal endoscope from the Shandong Provincial Drug Administration [1] Group 1 - Xinhua Medical announced the receipt of registration certificates for two medical devices [1] - The registered products are the surgical shadowless lamp and thoracoabdominal endoscope [1] - The registration certificate numbers are Lu Xie Zhuan Zheng 20252010721 and Lu Xie Zhuan Zheng 20252060702 [1]

证券日报网讯12月4日，新华医疗（600587）在互动平台回答投资者提问时表示，公司整体运营稳健， 坚持高质量发展，具体经营情况敬请关注公司定期报告。 ...

Core Viewpoint - Xinhua Medical (600587) is advancing its lower limb exoskeleton robot, with a patent application accepted by the National Intellectual Property Administration, indicating progress in innovation and potential market entry [1] Group 1: Product Development - The lower limb exoskeleton robot is currently in the functional prototype development stage, with completion of product development expected by 2026 [1] - The company anticipates obtaining medical device registration certification by 2027, which is crucial for market launch [1] Group 2: Market Applications - The exoskeleton robot is designed for multiple application scenarios, including hospitals, communities, homes, and elderly care institutions, highlighting its versatility and potential market reach [1]